Pharmaceutical Technology® sat down with Stefan Verheyden, Global Vice President Sales Pharma & Biopharma Solutions Injectables at Gerresheimer, to talk about the primary and secondary packaging solutions Gerresheimer and Bormioli Pharma will be showcasing at Pharmapack Europe 2025 in Paris, France from January 22–23.

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.

2024年9月10日 · Excipients commonly make up the largest proportion of many drug dosage forms, performing specific functions, such as modifying API release, enhancing drug stability, or masking the taste of the active ingredients, among others.

2024年10月23日 · In September 2024, the much-anticipated update to FDA’s Guidance for Industry, Control of Nitrosamine Impurities in Human Drugs was published (1). This update is being called Revision 2 by the agency; the original guidance was published in 2020 and updated in February 2021.

2021年10月2日 · Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, answers some commonly asked questions about aseptic processing.

2024年12月6日 · FDA announced a draft guidance on Dec. 5, 2024 that explains the procedures and criteria for the agency’s accelerated drug approval for serious conditions.

2023年3月3日 · PAT is crucial to process control and real-time release in continuous manufacturing of solid-dosage drugs. Advances in process analytical technology (PAT) are enabling increased use of in-line PAT instruments for real-time measurement in continuous manufacturing (CM) of oral solid dosage (OSD) drugs.

2020年4月1日 · Cytiva is the new name of the former GE Healthcare Life Sciences biopharma business following its acquisition by Danaher Corporation, according to an April 1, 2020 announcement.

This Behind the Headlines news roundup panel discussion on recent news items includes updates regarding sickle cell therapies (e.g,, Pfizer’s withdrawal of Oxbryta and Vertex’s choosing of Lonza as the commercial manufacturer of Casgevy); Emergent BioSolutions $400 million BARDA contract for an mpox vaccine; and the first in a generation novel schizophrenia drug, Cobenfy (xanomeline and ...

Edwin Stone, Bernard Sagaert, and Khaled Yamout go behind the headlines to discuss what the ongoing measles outbreak in the UK means for pandemic preparedness and anti-vaccination trends; new mRNA approaches; and what Roche’s acquisition of …